2018
DOI: 10.1038/s12276-018-0096-z
|View full text |Cite
|
Sign up to set email alerts
|

An anti-EGFR × cotinine bispecific antibody complexed with cotinine-conjugated duocarmycin inhibits growth of EGFR-positive cancer cells with KRAS mutations

Abstract: Antibody-drug conjugates (ADCs) can selectively deliver cytotoxic agents to tumor cells and are frequently more potent than naked antibodies. However, optimization of the conjugation process between antibodies and cytotoxic agents and characterization of ADCs are laborious and time-consuming processes. Here, we describe a novel ADC platform using a tetravalent bispecific antibody that simultaneously binds to the tumor-associated antigen and a hapten conjugated to a cytotoxic agent. We selected cotinine as the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 50 publications
0
8
0
Order By: Relevance
“…The genes encoding the selected scFv clones were cloned into a modified mammalian expression vector, containing the hFc or hCκ at the C terminus ( 44 , 47 ), before being transfected and purified by affinity chromatography, as described above. Genes encoding V H and V λ were amplified, cloned into a mammalian expression vector containing the CH1 and hinge regions of human IgG2 fused to the CH2 and CH3 regions of human IgG4 ( 48 , 49 ), and transfected into Expi293F cells (Invitrogen) as described previously ( 50 ). Then, IgG2/4 was purified by affinity chromatography using MabSelect columns with the AKTA pure chromatography system (GE Healthcare) following the manufacturer’s protocol.…”
Section: Methodsmentioning
confidence: 99%
“…The genes encoding the selected scFv clones were cloned into a modified mammalian expression vector, containing the hFc or hCκ at the C terminus ( 44 , 47 ), before being transfected and purified by affinity chromatography, as described above. Genes encoding V H and V λ were amplified, cloned into a mammalian expression vector containing the CH1 and hinge regions of human IgG2 fused to the CH2 and CH3 regions of human IgG4 ( 48 , 49 ), and transfected into Expi293F cells (Invitrogen) as described previously ( 50 ). Then, IgG2/4 was purified by affinity chromatography using MabSelect columns with the AKTA pure chromatography system (GE Healthcare) following the manufacturer’s protocol.…”
Section: Methodsmentioning
confidence: 99%
“…The variable genes encoding clone 44 were cloned into a modified expression vector containing the human IgG4 construct, and transfected into Expi293F cells (Invitrogen) as described previously ( 26 ). IgG was purified by affinity chromatography using MabSelect columns with the AKTA Pure chromatography system (GE Healthcare, Chicago, IL, USA) following the manufacturer's protocol.…”
Section: Methodsmentioning
confidence: 99%
“…For the expression of IgG 1 , genes encoding V H and V L were amplified from the phage clones, cloned into a mammalian expression vector, and transfected into HEK293F cells. Then, IgG 1 was purified by Protein A affinity chromatography as described previously [68]. Then the eluate containing IgG 1 was subjected to gel filtration chromatography.…”
Section: Methodsmentioning
confidence: 99%